Evaluation of Treosulfan Versus Melphalan Conditioning Followed by PTCy in Patients With AML and MDS Undergoing Allogeneic Transplantation

Clinical trial NCT07025824 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07025824
Sponsor: Technische Universität Dresden
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

AML - Acute Myeloid Leukemia MDS (Myelodysplastic Syndrome)

Start date: 2025-09-01
Primary completion: 2028-12-01
Enrollment: 220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.